Kewaunee Scientific Corporation reported earnings results for the third quarter and nine months ended January 31, 2022. For the third quarter, the company reported sales was USD 40.63 million compared to USD 33.34 million a year ago. Net loss was USD 1.32 million compared to net income of USD 0.081 million a year ago. Basic loss per share from continuing operations was USD 0.47 compared to basic earnings per share from continuing operations of USD 0.03 a year ago. Diluted loss per share from continuing operations was USD 0.47 compared to diluted earnings per share from continuing operations of USD 0.03 a year ago.
For the nine months, sales was USD 119.16 million compared to USD 108.76 million a year ago. Net loss was USD 5.76 million compared to USD 0.697 million a year ago. Basic loss per share from continuing operations was USD 2.07 compared to USD 0.25 a year ago. Diluted loss per share from continuing operations was USD 2.07 compared to USD 0.25 a year ago.